OptimizeRx’s mission and passion continue to power drug maker brand awareness with prescribing physicians through patient treatment initiation, affordability and adherence. These efforts are packaged in a comprehensive, best-in-class enterprise solutions suite.
Earlier this year, OptimizeRx provided its 2023 Midyear Strategic update, stating that the company spent two years developing its RWD.AI platform to extend engagement points with the same pool of prescribers outside the EHR and into care-adjacent digital settings such as social media where it has access to over 2 million HCP profiles and 90% of the nation’s health system intranet/websites.
Through M&A and strategic partnerships, OptimizeRx also stated that the company was actively seeking ways to further enhance revenue streams through omni-channel expansion, proprietary data analytics and insight generation.
OptimizeRx recently signed an agreement to acquire Medicx Health, a leading healthcare consumer-focused omnichannel marketing and analytics company.
The acquisition of Medicx further advances OptimizeRx’s mission to create a more informed and empowered healthcare community using new technology solutions. The addition of the Medicx patient and HCP-focused Micro-Neighborhood® Targeting Platform, built on its MX# advanced identity resolution technology, to OptimizeRx’s HCP-focused Dynamic Audience Activation Platform (DAAP) is expected to provide a single source of innovative technologies that will enhance the reach and efficacy of healthcare marketing for life sciences organizations.
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey.
Connecting over 2 million U.S. healthcare providers and millions of their patients through an intelligent technology platform embedded within a proprietary digital point-of-care network, as well as web display and social media, OptimizeRx helps life sciences organizations engage and support their customers.
Takeaway: As part of OptimizeRx, Medicx technology and analytics solutions is expected to expand OptimizeRx’s addressable footprint in life science commercial digital budgets, a business area that is forecasted to grow 15% to 20% per year, and further enhance the company’s position as a leading player in the digital pharma marketing landscape.